Argenta, the international animal health CRO and CMO based in the USA and New Zealand, has appointed Rich Myer, MBA, as Senior Director of Business Development. Rich will guide the company’s business development implementing standard processes, delivering exceptional customer service to clients and expanding partnership and alliance opportunities.
Rich has an MBA from Purdue University and almost 20 years experience in BD roles within the pharmaceutical industry. His most recent position was with MDS Pharma/Xcelience where he led the BD function. He will be based in the US but will work closely with both the US and NZ R&D and manufacturing businesses.
Argenta’s CEO, Doug Cleverly, says that Rich’s extensive experience in business processes and deep understanding of all facets of the Chemistry, Manufacturing, and Controls (CMC) phase of pharmaceutical development will be a significant asset to our company. “”Having a dedicated client-focused resource based in the northern hemisphere will greatly assist our clients by expanding our reach across time zones ensuring that client communication is always timely and informed. As we continue to grow within the US and EU markets, Rich’s role will evolve and expand over time with the addition of further resources to ensure that we maintain our gold standard client support.””